ICUCW
SeaStar Medical Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.02
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-24.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 10, 2026 | Van Heel Kenneth · director | A-Award | 3,000 | $0.00 |
| Feb 10, 2026 | Neuman John · director | A-Award | 3,000 | $0.00 |
| Feb 10, 2026 | Vincent Bernadette N · director | A-Award | 3,000 | $0.00 |
| Feb 10, 2026 | Baird Jennifer A · director | A-Award | 3,000 | $0.00 |
| Feb 10, 2026 | Towne Bradford K · officer: Principal Accounting Officer | A-Award | 7,500 | $0.00 |
| Feb 10, 2026 | Chung Kevin · officer: Chief Medical Officer | A-Award | 15,000 | $0.00 |
| Feb 10, 2026 | Schlorff Eric · officer: Chief Executive Officer | A-Award | 30,000 | $0.00 |
| Dec 22, 2025 | Baird Jennifer A · director | Purchase | 4,200 | $0.24 |
| Dec 11, 2025 | Messinger Michael · officer: Chief Financial Officer | Purchase | 14,500 | $0.35 |
| Aug 28, 2025 | Van Heel Kenneth · director | Purchase | 10,000 | $0.86 |
| Aug 28, 2025 | Van Heel Kenneth · director | Purchase | 25,000 | $0.89 |
| Aug 25, 2025 | Chung Kevin · officer: Chief Medical Officer | Purchase | 10,000 | $0.80 |
| Jul 16, 2025 | Baird Jennifer A · director | A-Award | 4,000 | $0.00 |
| Jul 16, 2025 | Neuman John · director | A-Award | 4,000 | $0.00 |
| Jul 16, 2025 | Neuman John · director | M-Exempt | 2,667 | $0.00 |
| Jul 16, 2025 | Vincent Bernadette N · director | A-Award | 4,000 | $0.00 |
| Jul 16, 2025 | Vincent Bernadette N · director | M-Exempt | 2,667 | $0.00 |
| Jul 16, 2025 | Van Heel Kenneth · director | A-Award | 4,000 | $0.00 |
| Jul 16, 2025 | Van Heel Kenneth · director | M-Exempt | 4,000 | $0.00 |
| Jul 3, 2025 | Chung Kevin · officer: Chief Medical Officer | M-Exempt | 5,000 | $0.00 |
| Jul 3, 2025 | Schlorff Eric · director, officer: Chief Executive Officer | M-Exempt | 21,667 | $0.00 |
| Jul 2, 2025 | Baird Jennifer A · director | Purchase | 10,000 | $0.42 |
| Jul 2, 2025 | Baird Jennifer A · director | M-Exempt | 2,667 | $0.00 |
| Jun 27, 2025 | Neuman John · director | Purchase | 40,000 | $0.36 |
| May 22, 2025 | Baird Jennifer A · director | Purchase | 10,000 | $1.28 |
| May 20, 2025 | Chung Kevin · officer: Chief Medical Officer | Purchase | 4,500 | $1.25 |
| Apr 3, 2025 | Chung Kevin · officer: Chief Medical Officer | A-Award | 15,000 | $0.00 |
| Apr 3, 2025 | Green David A · officer: Chief Financial Officer | A-Award | 15,000 | $0.00 |
| Feb 27, 2025 | Neuman John · director | Purchase | 10,000 | $2.04 |
| Dec 3, 2024 | Baird Jennifer A · director | A-Award | 8,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 0Reduced 2Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 245,200 | May 15, 2026 |
| LINDEN ADVISORS LP | Unchanged | 218,073 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 211,381 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Unchanged | 211,381 | Mar 25, 2026 |
| LMR PARTNERS LLP | Unchanged | 125,000 | May 15, 2026 |
| CLEAR STREET GROUP INC. | Reduced | 46,490 | May 15, 2026 |
| TENOR CAPITAL MANAGEMENT CO., L.P. | Unchanged | 40,000 | May 15, 2026 |
| EQUITEC PROPRIETARY MARKETS, LLC | Unchanged | 35,700 | May 11, 2026 |
| CRUISER CAPITAL ADVISORS, LLC | Unchanged | 32,473 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Unchanged | 22,500 | May 15, 2026 |
| WOLVERINE ASSET MANAGEMENT LLC | Unchanged | 12,281 | May 4, 2026 |
| UBS GROUP AG | New Position | 717 | May 5, 2026 |
| EQUITEC PROPRIETARY MARKETS, LLC | Sold Out | 0 | May 11, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| LINDEN ADVISORS LP | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 10, 2026